The US Oncology Network:企業の戦略的SWOT分析

◆英語タイトル:The US Oncology Network - Strategic SWOT Analysis Review
◆商品コード:DATA904C13367
◆発行会社(調査会社):GlobalData
◆発行日:2019年2月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

The US Oncology Network – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

The US Oncology Network (US Oncology) formerly US Oncology, Inc., a subsidiary of McKesson Corporation, is an integrated oncology network formed by community-based oncology physicians and clinicians focused on advancing cancer care. The organization by utilizing the information technology, refined evidence-based medicine guidelines, shared best practices and quality measurements, improve patient outcomes and advance the quality, safety, and science of cancer care. It offers iknowMed, an oncology-specific electronic health record (EHR), developed by oncologists to meet the unique needs of oncology practices and cancer patients. It is supported by McKesson Specialty Health, a division of McKesson Corp. US Oncology is headquartered in Woodlands, Texas, the US.

The US Oncology Network Key Recent Developments

Nov 30,2018: US Oncology Research announces schedule of presentations at the 2018 American Society of Hematology Annual Meeting and Exposition
Aug 06,2018: Progressive Care Integrates with Illinois Cancer Specialists to Join The US Oncology Network
May 30,2018: Oncologists from The US Oncology Network and US Oncology Research to Present Data from More Than 40 Abstracts During the 54th Annual ASCO Meeting
May 16,2018: Real-World Evidence from McKesson Supports First-Ever FDA Approval for Metastatic Merkel Cell Carcinoma Drug
Apr 17,2018: The US Oncology Network Adopts ProKnow for Network-wide EPIQ Initiative

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
The US Oncology Network – Key Facts
The US Oncology Network – Key Employees
The US Oncology Network – Major Products and Services
The US Oncology Network – History
The US Oncology Network – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
The US Oncology Network – Business Description
The US Oncology Network – SWOT Analysis
SWOT Analysis – Overview
The US Oncology Network – Strengths
The US Oncology Network – Weaknesses
The US Oncology Network – Opportunities
The US Oncology Network – Threats
The US Oncology Network – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
The US Oncology Network, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
The US Oncology Network, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
The US Oncology Network, Recent Deals Summary
Section 4 – Company’s Recent Developments
Nov 30, 2018: US Oncology Research announces schedule of presentations at the 2018 American Society of Hematology Annual Meeting and Exposition
Aug 06, 2018: Progressive Care Integrates with Illinois Cancer Specialists to Join The US Oncology Network
May 30, 2018: Oncologists from The US Oncology Network and US Oncology Research to Present Data from More Than 40 Abstracts During the 54th Annual ASCO Meeting
May 16, 2018: Real-World Evidence from McKesson Supports First-Ever FDA Approval for Metastatic Merkel Cell Carcinoma Drug
Apr 17, 2018: The US Oncology Network Adopts ProKnow for Network-wide EPIQ Initiative
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
The US Oncology Network, Key Facts
The US Oncology Network, Key Employees
The US Oncology Network, Major Products and Services
The US Oncology Network, History
The US Oncology Network, Subsidiaries
The US Oncology Network, Joint Venture
The US Oncology Network, Key Competitors
The US Oncology Network, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
The US Oncology Network, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
The US Oncology Network, Recent Deals Summary

List of Figures
The US Oncology Network, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
The US Oncology Network, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[The US Oncology Network:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nanophase Technologies Corp (NANX):企業の財務・戦略的SWOT分析
    Nanophase Technologies Corp (NANX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • GW Pharmaceuticals Plc (GWP):製薬・医療:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • The Netherlands Cancer Institute-製薬・医療分野:企業M&A・提携分析
    Summary The Netherlands Cancer Institute (NCI) is a research institute that offers cancer research and treatment services. The institute conducts research in the areas of cell biology, diagnostic oncology, medical oncology, molecular carcinogenesis, biochemistry, biological stress response, gene reg …
  • Solvay SA (SOLB)-エネルギー分野:企業M&A・提携分析
    Summary Solvay SA (Solvay) is a chemical manufacturing company, which carries out production of specialty polymers, essential chemicals, silica and rare earth systems, consumer chemicals, polyamide and intermediates, vinyls and acetate tow. Its products include chemical products such as barium stron …
  • Cara Therapeutics Inc (CARA)-医療機器分野:企業M&A・提携分析
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a clinical-stage biotechnology company that develops novel therapeutics for pain and inflammation and pruritus. The company products include kappa receptor agonists and cannabinoid receptors. It offers products for therapeutic areas which include …
  • Generali Deutschland AG:企業の戦略・SWOT・財務情報
    Generali Deutschland AG - Strategy, SWOT and Corporate Finance Report Summary Generali Deutschland AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Intezyne Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Intezyne Inc (Intezyne) is a biotechnology company that develops product candidates for the treatment of various cancer tumors. The company offers anti-cancer agents and IVECT method to improve cancer therapy. It provides compounds that are cellular or molecularly targeted or have tumor-spec …
  • JEOL Ltd. (6951):企業の財務・戦略的SWOT分析
    JEOL Ltd. (6951) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • e-Therapeutics Plc (ETX):企業の財務・戦略的SWOT分析
    e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • AcelRx Pharmaceuticals Inc (ACRX):企業の財務・戦略的SWOT分析
    AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Cell Therapy Catapult Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cell Therapy Catapult Ltd (Catapult) is a provider of cell and gene therapy life cycle solutions. The company offers services such as industrialization, manufacturing, regulatory, health economics and market access, non-clinical safety and clinical operations. Its health economics and market …
  • Pivotal Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pivotal Therapeutics Inc (Pivotal Therapeutics) is a pharmaceutical company that develops and markets Omega-3 based therapies and therapeutic products for cardiovascular disorders. The company offers products such as VASCAZEN, a medical food formulated for the dietary management of an Omega- …
  • Suzuken Co., Ltd.:企業の戦略・SWOT・財務情報
    Suzuken Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Suzuken Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • DesignMedix Inc-製薬・医療分野:企業M&A・提携分析
    Summary DesignMedix Inc (DesignMedix) is a biotechnology company that develop drugs to overcome drug resistance in multiple diseases including malaria and diarrhea. The company focuses on the development of malaria cure drugs, malaria preventive drugs and anti-bacterial drugs. Its malaria cure drugs …
  • Acron (AKRN):企業の財務・戦略的SWOT分析
    Summary Acron produces and commercializes mineral fertilizers. The company offers ammonium nitrate, urea, ammonia, apatite concentrate, methanol, formalin, urea-formaldehyde resins, melamine-urea-formaldehyde resins and dipping resins, cerium, lanthanum, neodymium and didymium. Its products finds ap …
  • Stereotaxis Inc (STXS):製薬・医療:M&Aディール及び事業提携情報
    Summary Stereotaxis Inc (Stereotaxis) designs, manufactures and markets robotic systems and instruments for electrophysiologists for the treatment of cardiac arrhythmias. Its flagship product, Epoch solution is an advanced remote robotic navigation system for use in interventional lab for the treatm …
  • Kwality Group:企業の戦略・SWOT・財務分析
    Kwality Group - Strategy, SWOT and Corporate Finance Report Summary Kwality Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • AstraZeneca Plc (AZN)-医療機器分野:企業M&A・提携分析
    Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and n …
  • Hydrogenics Corporation (HYG):企業の財務・戦略的SWOT分析
    Hydrogenics Corporation (HYG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Stock Spirits Group PLC:企業の戦略・SWOT・財務分析
    Stock Spirits Group PLC - Strategy, SWOT and Corporate Finance Report Summary Stock Spirits Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆